Kangdi Tech announced that it has received $7,200,000 in angel round of funding led by Shanghai Bio-heart Biological Technology Co., Ltd. on September 6, 2022.
Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2 HKD | -6.10% | -8.26% | -41.52% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.52% | 6.23Cr | |
+8.29% | 12TCr | |
-5.61% | 1.12TCr | |
+4.83% | 916.62Cr | |
+39.60% | 558.62Cr | |
-22.04% | 471.19Cr | |
+8.39% | 344.12Cr | |
-6.28% | 287.97Cr | |
-10.23% | 211.11Cr | |
-5.99% | 209.29Cr |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Kangdi Tech announced that it has received $7.200000 million in funding from Shanghai Bio-heart Biological Technology Co., Ltd. and other investors.